Review of Tralokinumab in the Treatment of Atopic Dermatitis.
Rohan SinghAlexandra TaylorMilaan A ShahLindsay C StrowdSteven Richard FeldmanPublished in: The Annals of pharmacotherapy (2022)
Tralokinumab is an efficacious and safe systemic treatment for moderate-to-severe AD.